The Endpoints Company
Endpoints News

Led by John Carroll, one of the most experienced biotech reporters in the world, Endpoints covers top breaking news in hubs from Shanghai to San Francisco, Boston/Cambridge to the Golden Triangle, and beyond.

The mission: bring our subscribers all the top news in the drug R&D world, with a rich and unique context that draws on original interviews and expert insights on the key trends driving the field today. And to deliver it directly — entire articles, not just snippets — in a reliable daily email report. For the widest possible distribution, audiences worldwide can discover our news reported in real-time on the web at endpts.com.

We also add a regular series of live panel discussions and in-depth articles covering biopharma, from preclinical advances through post-approval breakthroughs. For anyone who wants to stay on top of the fast-breaking events in the industry, Endpoints News is an indispensable guide to your future.


Key contacts:

Mike Peck
Sales & Conferences Chief

mike@endpointsnews.com

Arsalan Arif
Founder & Publisher

aa@endpointsnews.com


 

Audience

Company Profile
Email subscribers

Sample Companies

AbbVie, Allergan, Alexion, Alnylam, Amgen, Bayer, Beigene, bluebird bio, BMS, Celgene, Checkmate Pharma, Covance, CRISPR Therapeutics, Dicerna, EMD Serono, Flagship Pioneering, Genentech, Gilead, GlaxoSmithKline, IQVIA, J&J, Lilly, MD Anderson, Medimmune, Merck, Moderna, Novartis, Orbimed, Parexel, Pfizer, PPD, Prothena, Recursion Pharma, Regeneron, Roche, Sanofi, Shire, Spark Therapeutics, Takeda, Teva, Versant Ventures, Vertex, and thousands more ...

Top 20 of 25 Biopharmas
Pay for their employees to read Endpoints

7 Day Active Users
Immediately addressable

Job Function

Reader Acquisition

Top 10 countries

endpts.com Monthly Visits

 

Calendar

New topics added weekly. Check back regularly or schedule a chat with Endpoints for custom editorial or content ideas.

Q2


When
Description
Type
April The next-generation of biopharma leaders Link Special Report
April Alzheimer's R&D revisited Link Deep Dive
May Top 20 cancer drugs on the market Special Report
May The 25 most influential people in biopharma Special Report
May The top 15 biopharma R&D pay packages Special Report
May The immunotherapy strategy report Deep Dive
June ASCO 2018 weekend coverage Special Report
June BIO 2018 convention coverage Special Report
June The ROI of drug development (BIO 2018 affilliated) Event
June The Endpoints 100 CEO survey Survey

H2


When
Description
Type
July Top 20 drugs in the late-stage pipeline Special Report
July Protecting patents, or excluding competition? Webinar
August The new wave of Alzheimer's research Webinar
September Depression: replacing a generation of ineffective therapies Deep Dive
September The late-stage players in the NASH pipeline Webinar
October Endpoints London Biotech Summit Event
December ASH conference coverage Special Report
December Diabetes and Obesity R&D Deep Dive

Events

We leverage unique access to the world’s most influential biopharma leaders, policy-makers and entrepreneurs to convene and harness their collective knowledge. Through panel discussions, interactive debates and high-level networking we address today’s critical issues and discover innovative solutions.

Boston, MA

The ROI of Drug Development

5 June 2018 — 7:00am

Affiliated with 2018 BIO Convention
Format
Served breakfast, followed by panel discussion w/ top newsmakers
Topics
R&D efficiency, clinical development, path to innovation

Endpoints News editor John Carroll is bringing together some of the world’s top authorities on designing and executing an R&D strategy that will deliver the maximum return on investment. After falling steadily over the past decade, there’s an unprecedented push to create a profitable and sustainable strategy for developing new drugs and finally delivering a boost on ROI. What have the top players done right, and where have they gone wrong? What role will AI and other new technologies play in improving R&D efficiency? And how will these ideas influence the work now underway at your biotech company? This is a discussion that centers on the biggest issues now confronting the $160 billion drug R&D industry. And you won’t want to miss out.

Presenting
Partner
Supporter
Hurry, sponsorship opportunities end soon. Click here to schedule a meeting with Endpoints.
London, UK

Endpoints London Biotech Summit

October 2018

Format
Half-day, multiple panels
Topics
UK biotech, financing, next-gen therapies

Endpoints News Editor John Carroll is bringing together the top players in the Golden Triangle for a special half-day event that will include panels on the latest biotech financing trends, pipeline design and a special focus on the exploding field of cancer drug development. Carroll and colleagues will moderate several discussions on the key issues facing the UK biotech industry, joined by an international group of commentators.

We'll talk financing trends. During a period of unprecedented capital flows into new drug developers around the world, highlighting the arrival of new Chinese investors on the global scene, how does the Golden Triangle fare for venture investing and IPOs? What does the year ahead look like? And what new sources of financing should you be aware of?

And much of the investment cash bound for biotech has been funneled into oncology research, often funding duplicate programs for the same kind of cancer drugs. Where is that trend headed and what kind of next-gen therapies are likely to fare the best in 2019 and the years ahead?

Presenting
Partner
Supporter
Contact us now — Click here to schedule a meeting with Endpoints and learn about sponsorship options and presentation details.

Past Events

San Francisco

January 2018, San Francisco — #JPM18

Where is the cancer immunotherapy revolution headed?

Panelists
Herve Hoppenot (Incyte); Gideon Blumenthal (FDA), Ellen Sigal (Friends of Cancer Research), Jay Bradner (Novartis), Aiman Shalabi (Cancer Research Institute), David Brennan (AstraZeneca)
Format
Breakfast served, followed by panel discussion and Q&A
San Francisco

January 2017, San Francisco — #JPM17

Access and affordability in a new era of medicine

Panelists
Steve Pearon (ICER); Richard Pops (Alkermes), Brent Saunders (Allergan), Joaquin Duato (J&J), Stephen Ubl (PhRMA)
Format
Breakfast served, followed by panel discussion and Q&A
  • Space
    Friends of Cancer Research founder Ellen Sigal on stage
  • Space
    Novartis Institutes for BioMedical Research President Jay Bradner
  • Space
    Jay Bradner speaks with members of the Endpoints News audience after the event
  • Space
    John Carroll with Incyte CEO Herve Hoppenot
  • Space
    Packed house for an Endpoints News executive breakfast event
  • Space
    Endpoints audience members enjoying the networking

Sponsorship Rates

Advertising on the uncluttered Endpoints platform allows biopharma brands to stand out like nowhere else.

Read daily by thousands of business and science leaders engaged in drug R&D around the world, your sponsorship will be presented to the C-suite and to legions of team players who make biopharma turn. And we have sponsorship packages for all budgets and ambitions.

Your units will never compete against noisy "ad networks" because Endpoints strictly forbids third-party advertising. Put another way, the only ads readers will ever see on Endpoints are the ones booked directly through us. This is to keep engagement rates high for our clients and to prevent our audience from being aggregated and targeted for all other outside platforms.

All rates are a la carte below. Package discounts are available for integrated campaigns. Please contact an Endpoints representative for consultation.

Feature Edition Email Sponsor



Endpoints' flagship product. Published daily by 11a ET. A comprehensive look at the news, with no clicks required — the entire article text is included inside the email report. A clean and timeless design that lets both news content and sponsor messages shine.

Placement Duration Rate
Premier 1 week (5 insertions) $5,000
Top Story 1 week (5 insertions) $4,000
Integrated 1 week (5 insertions) $2,000
Protocols 1 week (5 insertions) $1,000
Callout or Billboard units accepted
Type Specs Size
Billboard 600x250
Plus up to 49-characters text line below billboard
100k
Callout 50 character bold headline
Plus up to 140-char description + call-to-action button + 300x90 logo
100k

Early Edition Email Sponsor


Never miss an important story again. Published by 7a ET, with a fun, skimmable outline of biopharma's most essential links around web in the past 24 hours. From the firehose of noise, we distill the signal for readers.

Placement Duration Rate
Premier 1 week (5 insertions) $4,000
Integrated 1 week (5 insertions) $2,000
Callout or Billboard units accepted
Type Specs Size
Billboard 600x250
Plus up to 49-characters text line below billboard
100k
Callout 50 character bold headline
Plus up to 140-char description + call-to-action button + 300x90 logo
100k

Dedicated Email Blasts


Distribution Count Rate
All Endpoints 26,000 $8,000
USA/Canada 19,000 $7,000
Massachusetts 3,000 $4,000
California 3,500 $4,000
Europe 3,000 $3,000
Specs
Blast 600-800 pixels max width
Valid HTML. Design for simplicity, structure w/ table element
500k

Web Advertising


Rates are weekly and reach figures are guaranteed minimums. No extra fees for overdelivery.

Rate
$6,000
Reach
100k desktop-only impressions, 45k visitors
Rate
$5,000
Reach
150k impressions, 70k visitors
Rate
$3,000 per week
Reach
100k impressions, 45k visitors
Rate
$3,000
Reach
100k visitors per week
Rate
$4,000 and up
Reach
80,000 visitors per week

Web — Homepage Specs

Type Dimensions Size Animation
Billboard 970x250 250k 30 seconds
Super Leaderboard 970x90
Expand to 970x250 for Desktop only
250k 30 seconds
Home Page Ears 184 x 90 (2 units)
Side-by-side Endpoints nameplate
15k Static

Web — Run-of-site Specs

Type Dimensions Size Animation
Billboard 970x250 200k initial 30 seconds
Super Leaderboard 970x90
Expand to 970x250 for Desktop only
250k 30 seconds
Article Box 300x250
Expand to left 504x250 for Desktop only
250k 30 seconds
Article Callout 50 character bold headline
Plus up to 140-char description + 300x90 logo text line below
100k None

Sponsored Posts


Type Placement Rate
Featured Sponsored Post Premium Homepage, Email Reports $5,000
Sponsored Post Website, Email Reports $2,500

Turnkey Content Sponsorships


Special Reports

Rate
$7,500 and up
Specs
Small Logo, Billboard, and Article Box
Reach
10 - 20k+ visitors
See planned topics in Calendar or talk to sales representative about potential ideas.

Deep Dives

Rate
$17,500 and up
Specs
Small Logo, Billboard, Article Box, and 600 word content insert
Reach
200+ registered leads (or) 10 - 30k+ visitors

Webinars


Rate
$17,500 and up
Expected Audience
200-600+ registrants
Format
Panel discussion, presentations, editorial, or custom
Includes
At least $10k worth of digital advertising
 

Contact Endpoints